Skip to content
★ Sign in to follow
RL

Rene Lenggenhager

CEO
Total declarations
4
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (1 ops.)
€80k

Latest filing published 01 Mar 2017 for BRUKER CORP, €75k.

Filing timeline

BuySale
Rene Lenggenhager

Insider track record

Disclosed buys
0
Disclosed sells
1
Signal history

Rene Lenggenhager: trading record in brief

Rene Lenggenhager discloses dealings in Bruker Corp to SEC (Form 4). The record holds 4 filings, for trades running from 1 December 2015 to 24 February 2017.

Every open-market trade on record is a sale: 1 sale worth €80k. Besides market trades, the filings include 2 share grants and 1 option exercise. 2017 to date brings no purchases and 1 sale.

The latest filing, published on 1 March 2017, reports an option exercise of €75k in Bruker Corp. The median gap between a trade and its publication by SEC (Form 4) is 4 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Rene Lenggenhager

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations4 total
  • ◇
    President, BioSpin GroupExecutivesBruker Corp
    79,486 USD27SEC
    3,539 shares@ US$22.4648.4% of flowCommon StockSEC:0001179110-17-003456:0
  • ▼
    President, BioSpin GroupExecutivesBruker Corp
    84,688 USD27SEC
    3,539 shares@ US$23.9351.6% of flowCommon StockSEC:0001179110-17-003456:1
  • ◆
    President, BioSpin GroupExecutivesBruker Corp
    0SEC
    5,634 shares0Common StockSEC:0001179110-16-030519:0
  • ◆
    President, BioSpin GroupExecutivesBruker Corp
    0SEC
    5,403 shares0Common StockSEC:0001179110-15-015634:0

4 of 4 declarations